Cargando…

FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke

The significance and utility of innovative imaging techniques in arterial clot analysis, which enable far more detailed and automated analysis compared to standard methods, are presented. The examination of two types of human thrombi is shown, representing the main ischemic stroke etiologies: fibrin...

Descripción completa

Detalles Bibliográficos
Autores principales: Blat, Aneta, Dybas, Jakub, Chrabaszcz, Karolina, Bulat, Katarzyna, Jasztal, Agnieszka, Kaczmarska, Magdalena, Pulyk, Roman, Popiela, Tadeusz, Slowik, Agnieszka, Malek, Kamilla, Adamski, Mateusz G., Marzec, Katarzyna M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820737/
https://www.ncbi.nlm.nih.gov/pubmed/31664105
http://dx.doi.org/10.1038/s41598-019-51932-0
_version_ 1783464005550997504
author Blat, Aneta
Dybas, Jakub
Chrabaszcz, Karolina
Bulat, Katarzyna
Jasztal, Agnieszka
Kaczmarska, Magdalena
Pulyk, Roman
Popiela, Tadeusz
Slowik, Agnieszka
Malek, Kamilla
Adamski, Mateusz G.
Marzec, Katarzyna M.
author_facet Blat, Aneta
Dybas, Jakub
Chrabaszcz, Karolina
Bulat, Katarzyna
Jasztal, Agnieszka
Kaczmarska, Magdalena
Pulyk, Roman
Popiela, Tadeusz
Slowik, Agnieszka
Malek, Kamilla
Adamski, Mateusz G.
Marzec, Katarzyna M.
author_sort Blat, Aneta
collection PubMed
description The significance and utility of innovative imaging techniques in arterial clot analysis, which enable far more detailed and automated analysis compared to standard methods, are presented. The examination of two types of human thrombi is shown, representing the main ischemic stroke etiologies: fibrin–predominant clot of large vessel origin and red blood cells–rich clot of cardioembolic origin. The synergy effect of Fourier–transform infrared spectroscopy (FTIR), Raman spectroscopy (RS) and atomic force microscopy (AFM) techniques supported by chemometrics in comparison with reference histological staining was presented. The main advantage of such approach refers to free–label and non–destructive quantitative imaging of clinically valid, biochemical parameters in whole sample (FTIR–low resolution) and selected regions (RS–ultra–high resolution). We may include here analysis of lipid content, its distribution and total degree of unsaturation as well as analysis of protein content (mainly fibrin and hemoproteins). The AFM studies enhanced the vibrational data, showed clearly shape and thickness of clot features as well as visualized the fibrin framework. The extraordinary sensitivity of FTIR and RS imaging toward detection and discrimination of clinically valid parameters in clot confirms its applicability in assessment of thrombi origin.
format Online
Article
Text
id pubmed-6820737
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-68207372019-11-04 FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke Blat, Aneta Dybas, Jakub Chrabaszcz, Karolina Bulat, Katarzyna Jasztal, Agnieszka Kaczmarska, Magdalena Pulyk, Roman Popiela, Tadeusz Slowik, Agnieszka Malek, Kamilla Adamski, Mateusz G. Marzec, Katarzyna M. Sci Rep Article The significance and utility of innovative imaging techniques in arterial clot analysis, which enable far more detailed and automated analysis compared to standard methods, are presented. The examination of two types of human thrombi is shown, representing the main ischemic stroke etiologies: fibrin–predominant clot of large vessel origin and red blood cells–rich clot of cardioembolic origin. The synergy effect of Fourier–transform infrared spectroscopy (FTIR), Raman spectroscopy (RS) and atomic force microscopy (AFM) techniques supported by chemometrics in comparison with reference histological staining was presented. The main advantage of such approach refers to free–label and non–destructive quantitative imaging of clinically valid, biochemical parameters in whole sample (FTIR–low resolution) and selected regions (RS–ultra–high resolution). We may include here analysis of lipid content, its distribution and total degree of unsaturation as well as analysis of protein content (mainly fibrin and hemoproteins). The AFM studies enhanced the vibrational data, showed clearly shape and thickness of clot features as well as visualized the fibrin framework. The extraordinary sensitivity of FTIR and RS imaging toward detection and discrimination of clinically valid parameters in clot confirms its applicability in assessment of thrombi origin. Nature Publishing Group UK 2019-10-29 /pmc/articles/PMC6820737/ /pubmed/31664105 http://dx.doi.org/10.1038/s41598-019-51932-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Blat, Aneta
Dybas, Jakub
Chrabaszcz, Karolina
Bulat, Katarzyna
Jasztal, Agnieszka
Kaczmarska, Magdalena
Pulyk, Roman
Popiela, Tadeusz
Slowik, Agnieszka
Malek, Kamilla
Adamski, Mateusz G.
Marzec, Katarzyna M.
FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title_full FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title_fullStr FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title_full_unstemmed FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title_short FTIR, Raman and AFM characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
title_sort ftir, raman and afm characterization of the clinically valid biochemical parameters of the thrombi in acute ischemic stroke
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6820737/
https://www.ncbi.nlm.nih.gov/pubmed/31664105
http://dx.doi.org/10.1038/s41598-019-51932-0
work_keys_str_mv AT blataneta ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT dybasjakub ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT chrabaszczkarolina ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT bulatkatarzyna ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT jasztalagnieszka ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT kaczmarskamagdalena ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT pulykroman ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT popielatadeusz ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT slowikagnieszka ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT malekkamilla ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT adamskimateuszg ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke
AT marzeckatarzynam ftirramanandafmcharacterizationoftheclinicallyvalidbiochemicalparametersofthethrombiinacuteischemicstroke